| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.18 | 0.08 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |